Clinical Trial Update: Topical Rapamycin for Fibrofolliculomas [Phase 3]

View source ↗

Summary

Phase 3 study evaluating topical rapamycin for fibrofolliculomas in Birt-Hogg-Dubé syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Birt-hogg-dubé Syndrome

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Birt-Hogg-Dubé Syndrome | Phase 3 | Status: COMPLETED